Table 1.
Baseline characteristics of all TS patients.
| Age at diagnosis, Median (Q1-Q3) | 17.00 (7.25–61.50) |
|---|---|
| Region, N (%) | |
| Pacific Coast | 76 (48.10%) |
| East | 57 (36.08%) |
| Northern Plains | 14 (8.86%) |
| Southwest | 11 (6.96%) |
| Race, N (%) | |
| White | 117 (76.47%) |
| Black | 28 (18.30%) |
| Asian or Pacific Islander | 7 (4.58%) |
| American Indian/Alaska Native | 1 (0.65%) |
| Marital status, N (%) | |
| Single (never married)/Unmarried or Domestic Partner | 104 (69.80%) |
| Married (including common law) | 38 (25.50%) |
| Divorced/separated/widowed | 7 (4.70%) |
| Year of diagnosis, N (%) | |
| 2006 | 12 (7.59%) |
| 2007 | 12 (7.59%) |
| 2008 | 22 (13.92%) |
| 2009 | 9 (5.70%) |
| 2010 | 10 (6.33%) |
| 2011 | 20 (12.66%) |
| 2012 | 15 (9.49%) |
| 2013 | 13 (8.23%) |
| 2014 | 16 (10.13%) |
| 2015 | 13 (8.23%) |
| 2016 | 16 (10.13%) |
| Differentiation grade, N (%) | |
| Well differentiated; Grade I (G1) | 24 (34.29%) |
| Moderately differentiated; Grade II (G2) | 7 (10.00%) |
| Poorly differentiated; Grade III (G3) | 16 (22.86%) |
| Undifferentiated; anaplastic; Grade IV (G4) | 23 (32.86%) |
| Laterality, N (%) | |
| Unilateral | 75 (47.47%) |
| Bilateral | 83 (52.53%) |
| Tumor size, N (%) | |
| <2.0 | 4 (3.25%) |
| 2.0–4.0 | 20 (16.26%) |
| ≥4.0 | 99 (80.49%) |
| Surgery, N (%) | |
| None | 2 (1.27%) |
| Partial dissection | 1 (0.63%) |
| Orchiectomy | 153 (96.84%) |
| Method unknown | 2 (1.27%) |
| RPLND, N (%) | |
| Yes | 36 (23.08%) |
| No | 120 (76.92%) |
| Radiotherapy, N (%) | |
| None | 117 (74.05%) |
| Adjuvant | 39 (24.68%) |
| Neoadjuvant | 2 (1.27%) |
| AFP, N (%) | |
| Normal | 20 (83.33%) |
| Normal–1,000 | 2 (8.33%) |
| 1,000–10,000 | 1 (4.17%) |
| >10,000 | 1 (4.17%) |
| hCG, N (%) | |
| Normal | 18 (78.26%) |
| Normal–5,000 | 5 (21.74%) |
| LDH, N (%) | |
| Normal | 11 (57.89%) |
| Normal–1.5N a | 5 (26.32%) |
| 1.5N - 10N | 3 (15.79%) |
| Metastasis, N (%) | |
| No | 95 (61.69%) |
| Localized | 31 (20.13%) |
| Distant | 28 (18.18%) |
| Invasion, N (%) | |
| Tis | 42 (30.43%) |
| T1 | 53 (38.41%) |
| T2 | 15 (10.87%) |
| T3 | 20 (14.49%) |
| T4 | 5 (3.62%) |
| >T4 | 3 (2.17%) |
Q, quartile; RPLND, retroperitoneal lymph node dissection; AFP, Alpha Fetoprotein; hCG, human Chorionic Gonadotropin; LDH, Lactate Dehydrogenase.
a
N, normal.